In this study, EGFR-activating mutation status and DNA copy number abundances of EGFR, ERBB2, ERBB3, and ERBB4 were measured in 261 surgically resected lung adenocarcinomas. The gene discussed is ERBB2; the disease is lung adenocarcinoma.